Changmao Biochemical Engineering Company Limited (HKG:0954)
Hong Kong
· Delayed Price · Currency is HKD 0.330
0.00 (0.00%)
Mar 9, 2026, 3:08 PM HKT
HKG:0954 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 543.27 | 584.79 | 637.08 | 730.03 | 547.98 | 444.11 | Upgrade
|
| Revenue Growth (YoY) | -16.97% | -8.21% | -12.73% | 33.22% | 23.39% | -10.21% | Upgrade
|
| Cost of Revenue | 528.4 | 567.09 | 572.72 | 549.2 | 491.74 | 348.66 | Upgrade
|
| Gross Profit | 14.87 | 17.71 | 64.36 | 180.83 | 56.23 | 95.45 | Upgrade
|
| Selling, General & Admin | 79.52 | 81.02 | 49.31 | 88.09 | 81.7 | 77.23 | Upgrade
|
| Other Operating Expenses | -4.54 | -6.85 | -6.83 | -3.61 | -4.66 | -2.59 | Upgrade
|
| Operating Expenses | 74.98 | 74.17 | 42.47 | 84.48 | 77.03 | 74.64 | Upgrade
|
| Operating Income | -60.11 | -56.46 | 21.88 | 96.35 | -20.8 | 20.81 | Upgrade
|
| Interest Expense | -14 | -11.36 | -7.58 | -2.67 | -1.95 | -0.06 | Upgrade
|
| Interest & Investment Income | 0.6 | 0.85 | 1.05 | 0.94 | 0.54 | 0.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.71 | 2.94 | -0.25 | 7.77 | -1.69 | -3.66 | Upgrade
|
| EBT Excluding Unusual Items | -71.81 | -64.03 | 15.11 | 102.39 | -23.91 | 17.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.02 | - | - | -1.53 | 1.05 | 1.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.62 | -2.62 | -1.14 | -4.35 | -1.67 | -1.29 | Upgrade
|
| Asset Writedown | -0.93 | -0.93 | -72.55 | -8.88 | -17.55 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 126.49 | - | Upgrade
|
| Pretax Income | -75.38 | -67.58 | -58.58 | 87.64 | 84.41 | 17.15 | Upgrade
|
| Income Tax Expense | 0.28 | 0.67 | 27.94 | 6.29 | 26.2 | 0.41 | Upgrade
|
| Earnings From Continuing Operations | -75.66 | -68.25 | -86.52 | 81.36 | 58.21 | 16.74 | Upgrade
|
| Minority Interest in Earnings | 0.42 | 0.01 | 0.46 | 0.07 | 0.11 | 0.08 | Upgrade
|
| Net Income | -75.25 | -68.24 | -86.06 | 81.42 | 58.32 | 16.83 | Upgrade
|
| Net Income to Common | -75.25 | -68.24 | -86.06 | 81.42 | 58.32 | 16.83 | Upgrade
|
| Net Income Growth | - | - | - | 39.62% | 246.57% | -71.14% | Upgrade
|
| Shares Outstanding (Basic) | 530 | 530 | 530 | 530 | 530 | 530 | Upgrade
|
| Shares Outstanding (Diluted) | 530 | 530 | 530 | 530 | 530 | 530 | Upgrade
|
| EPS (Basic) | -0.14 | -0.13 | -0.16 | 0.15 | 0.11 | 0.03 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.13 | -0.16 | 0.15 | 0.11 | 0.03 | Upgrade
|
| EPS Growth | - | - | - | 39.62% | 246.57% | -71.14% | Upgrade
|
| Free Cash Flow | -2.36 | -96.28 | -141.52 | -203.89 | -183.53 | -20.21 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.18 | -0.27 | -0.39 | -0.35 | -0.04 | Upgrade
|
| Dividend Per Share | - | - | - | 0.077 | - | 0.020 | Upgrade
|
| Dividend Growth | - | - | - | - | - | -63.64% | Upgrade
|
| Gross Margin | 2.74% | 3.03% | 10.10% | 24.77% | 10.26% | 21.49% | Upgrade
|
| Operating Margin | -11.06% | -9.65% | 3.44% | 13.20% | -3.80% | 4.69% | Upgrade
|
| Profit Margin | -13.85% | -11.67% | -13.51% | 11.15% | 10.64% | 3.79% | Upgrade
|
| Free Cash Flow Margin | -0.43% | -16.46% | -22.21% | -27.93% | -33.49% | -4.55% | Upgrade
|
| EBITDA | -35.71 | -13.9 | 61.56 | 125.74 | 6.08 | 52.28 | Upgrade
|
| EBITDA Margin | -6.57% | -2.38% | 9.66% | 17.22% | 1.11% | 11.77% | Upgrade
|
| D&A For EBITDA | 24.41 | 42.56 | 39.68 | 29.39 | 26.88 | 31.47 | Upgrade
|
| EBIT | -60.11 | -56.46 | 21.88 | 96.35 | -20.8 | 20.81 | Upgrade
|
| EBIT Margin | -11.06% | -9.65% | 3.44% | 13.20% | -3.80% | 4.69% | Upgrade
|
| Effective Tax Rate | - | - | - | 7.17% | 31.04% | 2.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.